DEC 21, 2019 10:50 PM PST

Improving Vaccines for Meningitis

WRITTEN BY: Nouran Amin

Scientists at the University of Nottingham are seeking new ways to improve vaccine use in the protection against the bacterium, Neisseria meningitides that leads to sepsis and meningitis. Findings of the study were published in the journal Frontiers in Microbiology and could have major implications for current marketed vaccines Trumenba and Bexsero that contain Factor H binding protein (FHbp)—which is a lipoprotein found on Neisseria bacterium.

Learn more about meningitis:

"The Trumenba vaccine currently used to protect against meningococcal group B is monovalent, it comprises two versions of the same antigen. The risk you take with monovalent vaccines is that isolates may have previously acquired mutations in the target or go on to acquire new mutations such that the target changes significantly from that contained within the formulation. This makes the vaccine less target-specific and less effective,” says Dr. Ruth Griffin, Assistant Professor in Microbial Pathogenesis from the School of Life Sciences at the University of Nottingham.

Bacterial meningitis is a life-threatening disease that poses a worldwide challenges with the increasing threat of antibiotic-resistant bacteria which is why vaccines need to be as effective as possible. Babies and adolescents are often at high risk of acquiring an infection and those that survive often live with life-long complications such as hearing loss, brain damage and organ damage.

"We analysed the FHbp sequence of almost 2000 isolates and experimentally tested 20 and saw a 100 percent correlation between mutations in the signal peptide sequence and inability to convert the precursor protein to the cleaved lipidated antigen,” says Dr. Griffin.

Source: University of Nottingham

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
DEC 27, 2019
Drug Discovery & Development
DEC 27, 2019
Acne Drug Linked to 10 Suicides
UK regulators claim to have found a link between at least ten suicides and a powerful acne drug, manufactured under the names Roaccutane and Accutane. Alth...
JAN 04, 2020
Cardiology
JAN 04, 2020
New Protein Therapy Improves Heart Attack Survival Rates
Heart disease is the top killer in the Western world. This is partially because, if one manages to survive an initial heart attack, oftentimes the scar tis...
JAN 16, 2020
Cancer
JAN 16, 2020
FLASH proton therapy: faster and more effective
A new technique called FLASH proposes a new type of radiation therapy. The technique is composed of an ultra-high dose rate of radiotherapy and uses electr...
JAN 21, 2020
Cannabis Sciences
JAN 21, 2020
Medical Marijuana Ineffective for Long Term Pain Management
Medicinal cannabis may not as effective as once thought as a solution for sleep problems for those with chronic pain in the long run, according to new find...
JAN 21, 2020
Drug Discovery & Development
JAN 21, 2020
Drug Targets Gastrointestinal Cancer
The FDA has recently approved Ayvakit (avapritinib) for the treatment of unresectable and metastatic gastrointestinal stromal tumor (GIST) that occurs most...
FEB 13, 2020
Cell & Molecular Biology
FEB 13, 2020
Study of Early-Onset Parkinson's Reveals Potential Therapeutic
Around 500,000 Americans are diagnosed with Parkinson's disease every year, and the rate of the disease is rising....
Loading Comments...